Suppr超能文献

[超声治疗在脓毒症大鼠模型中的疗效初步研究]

[Preliminary study on the efficacy of ultrasound therapy in the rat model of sepsis].

作者信息

Huang He, Cai Yu, Liang Licai, Shao Weijing, Xu Shuang, Zhou Yuran, Sun Peng

机构信息

Department of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.

Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China. Huang He is working on the Department of Emergency Medicine, General Hospital of Central Theatre Command of the Chinese People's Liberation Army, Wuhan 430070, Hubei, China. Corresponding author: Sun Peng, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Sep;33(9):1110-1115. doi: 10.3760/cma.j.cn121430-20210402-00497.

Abstract

OBJECTIVE

To investigate the possible mechanism of ultrasound therapy in the rat model of sepsis.

METHODS

Seventy-eight male Sprague-Dawley (SD) rats were randomly divided into Sham group (n = 12), septic model group (n = 22), ultrasound treatment group (n = 22), methyllycaconitine citrate (MLA) combined with ultrasound treatment group (n = 22). In the Sham group, only the abdomen was opened, the cecum was found to be free, without cecal ligation and puncture (CLP). In the septic model group, CLP was used to replicate the septic rat model. After operation, each group of rats were subcutaneously injected with preheated 37 centigrade normal saline. The rats in the ultrasound treatment group were treated with ultrasound [Philips IU22 L9-3 ultrasound instrument and 9 MHz probe were used to break the sequence in the spleen area once every 6 seconds, with 1 second for each time, the mechanical index (MI) was 0.72, and the treatment time was 10 minutes]. In the MLA combined with ultrasound treatment group, α7 nicotinic acetylcholine receptor (α7nAChR) specific blocker MLA 4 mg/kg was injected intraperitoneally 30 minutes before operation, and ultrasound treatment was performed 2 hours after operation. The levels of tumor necrosis factor-α (TNF-α) and interleukin (IL-1β, IL-6) in serum of each group were measured by enzyme-linked immunosorbent assay (ELISA) at 24 hours after operation. The 10-day survival rate of each group was recorded, and the symptoms of each group were evaluated by clinical disease score (CDS). The histopathological changes of lung and colon were observed under light microscope.

RESULTS

Compared with the Sham group, the 10-day survival rate of rats in the septic model group was decreased significantly [40% (4/10) vs. 100% (6/6)], the CDS was (10.73±2.19 vs. 6.17±0.58) and the levels of TNF-α, IL-6, and IL-1β were increased significantly at 24 hours after operation [TNF-α (ng/L): 42.00±8.92 vs. 13.16±3.19, IL-6 (ng/L): 129.37±25.04 vs. 63.99±12.92, IL-1β (ng/L): 254.98±67.27 vs. 76.83±25.39, all P < 0.01]. Compared with the septic model group, the survival rate in the ultrasound treatment group was improved [70% (7/10) vs. 40% (4/10)], but there was no significant difference (P > 0.05). The CDS (7.64±2.68 vs. 10.73±2.19) and the expressions of TNF-α, IL-6, and IL-1β were significantly reduced at 24 hours after operation [TNF-α (ng/L): 16.93±6.02 vs. 42.00±8.92, IL-6 (ng/L): 73.65±24.38 vs. 129.37±25.04, IL-1β (ng/L): 111.86±14.08 vs. 254.98±67.27, all P < 0.01]. Compared with the ultrasound treatment group, the survival rate in the MLA combined with ultrasound treatment group was reduced [60% (6/10) vs. 70% (7/10)], but the difference was not statistically significant (P > 0.05). CDS was significantly increased (9.55±2.72 vs. 7.64±2.68), and the levels of TNF-α, IL-6 and IL-1β were significantly increased at 24 hours after operation [TNF-α (ng/L): 34.61±7.89 vs. 16.93±6.02, IL-6 (ng/L): 112.92±10.42 vs. 73.65±24.38, IL-1β (ng/L): 212.57±32.16 vs. 111.86±14.08, all P < 0.01]. Microscopically, in the septic model group, the alveolar septum was thickened, a large number of inflammatory cells infiltrated, normal pulmonary reticular structure disappeared, and pulmonary interstitium showed obvious hemorrhage and edema, meanwhile, the structure of colonic villi was obviously abnormal, with cells were edema and inflammatory cell infiltration, and the arrangement was disordered, so that the subepithelial space and the top of it fell off. After ultrasound treatment, the thickness of the alveolar interval in rats was similar to that in Sham group, without obvious inflammatory cell infiltration, and the pulmonary reticular structure was relatively intact. At the same time, the morphology of colonic villi was basically normal and orderly, the edema of cell was not obvious, and subcutaneous space and tip fall off were not obvious. After being antagonized by MLA, the rat lung tissue showed thickened alveolar septum, inflammatory cell infiltration, incomplete pulmonary network structure, hemorrhage and edema in the interstitium. The villi structure of the colon was faintly visible, with obvious cell edema and inflammatory cell infiltration, and the arrangement was abnormal.

CONCLUSIONS

Ultrasound treatment improves the prognosis of septic rats, MLA can reverse the anti-inflammatory effect of ultrasound therapy by antagonizing α7nAChR, suggesting that the protective mechanism of ultrasound in sepsis may be related to activating the cholinergic anti-inflammatory pathway mediated by α7nAChR.

摘要

目的

探讨超声治疗在脓毒症大鼠模型中的可能机制。

方法

78只雄性Sprague-Dawley(SD)大鼠随机分为假手术组(n = 12)、脓毒症模型组(n = 22)、超声治疗组(n = 22)、甲基lycaconitine柠檬酸盐(MLA)联合超声治疗组(n = 22)。假手术组仅打开腹腔,发现盲肠游离,未进行盲肠结扎和穿刺(CLP)。脓毒症模型组采用CLP复制脓毒症大鼠模型。术后,每组大鼠皮下注射预热至37摄氏度的生理盐水。超声治疗组大鼠接受超声治疗[使用飞利浦IU22 L9-3超声仪和9 MHz探头,在脾脏区域每隔6秒进行一次序列击破,每次1秒,机械指数(MI)为0.72,治疗时间为10分钟]。MLA联合超声治疗组在手术前30分钟腹腔注射α7烟碱型乙酰胆碱受体(α7nAChR)特异性阻滞剂MLA 4 mg/kg,并在术后2小时进行超声治疗。术后24小时采用酶联免疫吸附测定(ELISA)法检测每组大鼠血清中肿瘤坏死因子-α(TNF-α)和白细胞介素(IL-1β、IL-6)水平。记录每组大鼠的10天生存率,并通过临床疾病评分(CDS)评估每组大鼠的症状。在光学显微镜下观察肺和结肠的组织病理学变化。

结果

与假手术组相比,脓毒症模型组大鼠10天生存率显著降低[40%(4/10)对100%(6/6)],CDS为(10.73±2.19对6.17±0.58),术后24小时TNF-α、IL-6和IL-1β水平显著升高[TNF-α(ng/L):42.00±8.92对13.16±3.19,IL-6(ng/L):129.37±25.04对63.99±12.92,IL-1β(ng/L):254.98±67.27对76.83±25.39,P均<0.01]。与脓毒症模型组相比,超声治疗组生存率有所提高[70%(7/10)对40%(4/10)],但差异无统计学意义(P>0.05)。术后24小时CDS(7.64±2.68对10.73±2.19)及TNF-α、IL-6和IL-1β表达显著降低[TNF-α(ng/L):16.93±6.02对42.00±8.92,IL-6(ng/L):73.65±24.38对129.37±25.04,IL-1β(ng/L):111.86±14.08对254.98±67.27,P均<0.01]。与超声治疗组相比,MLA联合超声治疗组生存率降低[60%(6/10)对70%(7/10)],但差异无统计学意义(P>0.05)。CDS显著升高(9.55±2.72对7.64±2.68),术后24小时TNF-α、IL-6和IL-1β水平显著升高[TNF-α(ng/L):34.61±7.89对16.93±6.02,IL-6(ng/L):112.92±10.42对73.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验